Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
about
Soft fluorescent nanomaterials for biological and biomedical imagingDevelopment of nanoscale approaches for ovarian cancer therapeutics and diagnosticsSynthesis of phase-shift nanoemulsions with narrow size distributions for acoustic droplet vaporization and bubble-enhanced ultrasound-mediated ablationAccumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivoNanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceDecationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapyFunctional core/shell drug nanoparticles for highly effective synergistic cancer therapy.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.Scalable imprinting of shape-specific polymeric nanocarriers using a release layer of switchable water solubilityEvaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationIntegrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living miceOptimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy.Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanomaBridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.Nano-graphene oxide: a potential multifunctional platform for cancer therapy.In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics.Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for BioimagingTargeted delivery of nano-PTX to the brain tumor-associated macrophagesImproved Targeting of Cancers with Nanotherapeutics.Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.Near-infrared fluorescence amplified organic nanoparticles with aggregation-induced emission characteristics for in vivo imaging.Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location.Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.Intended and Unintended Targeting of Polymeric Nanocarriers: The Case of Modified Poly(glycerol adipate) Nanoparticles.The new supramolecular nano-aggregate curcumin-cucurbit[7]uril: synthesis, photophysical properties and biocompatibility evaluation.IR-780-loaded polymeric micelles enhance the efficacy of photothermal therapy in treating breast cancer lymphatic metastasis in mice.Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug deliveryCo-solvent polarity controlled self-assembly of tetraphenylethylene-buried amphiphile for size-regulated tumor accumulation
P2860
Q26866189-84F87D63-3E34-4BC6-853A-E161D771BF6DQ30421664-2969B959-0742-466C-9E04-8EBE781C6A58Q30430901-0BA59075-09C9-4963-AB97-1A37F598E6AEQ30443425-AF2CF1EF-CC36-47E6-970A-6A9AE4A66075Q33759991-C9BD1614-545B-4D0F-AEF9-360FD75115CDQ34626943-47515B6B-D489-4AFE-B465-3AA60AB8ABDAQ35130422-6E724673-7156-4B67-BAB1-190EC3FC0641Q35232504-1C6F98C5-92A3-4895-8240-6E6ADD265701Q35856885-5C7E07FF-39C6-45B9-BFC0-9AF0C8C2A8B2Q36113655-2E6FAE43-D21C-4E1F-A2E0-C5367B87E6A2Q36454892-B3C5AB4F-ACFC-443B-9805-1F610B5BB73DQ36934007-213C759B-3C1D-484C-975B-4DBA58E27601Q37142585-3FDED0E6-FEA0-44B4-BE34-AC0D60D603CBQ37641818-9C9D92B9-9B8D-47B4-AB58-4FAC1EA2387CQ37702351-F76DCE85-C83D-48E1-AB50-8AA78E012A10Q38075542-B75AE0B0-F59A-41D8-8E85-FE83DDBE99ACQ38090525-A80467DF-A0B4-42A5-AE69-A240EFA53C33Q38092811-2BD58F3E-86B7-47A7-8EBB-B5E734FB342EQ38405765-876C27A9-7811-4227-AB71-13E3FA7E38F3Q38686516-A49221DD-A986-4EA3-9545-E7C3DA7D68C8Q38691793-202BFEFB-11E9-4735-98FB-66881D948D35Q38744232-C7E6CD7F-B4A6-4885-95F2-8CC2BE6E5EC8Q39050920-69568BE3-B0D8-49EB-80B1-966D96349711Q39114835-F0EE34D9-AFE7-45BC-B1BE-47C8F9ACEE70Q39393477-0D779BA1-333E-4CD5-BCFF-034C64FF6876Q40090893-A7814C30-9994-4EC6-BF58-C020AFFC689DQ42809958-7C93F4E8-93AC-416A-A311-CFBBBA205EE9Q44870836-4C209D85-ECC7-411E-B27C-4989BEDB3B20Q47228177-E38D543E-E2DE-4B83-8F0D-4DBFF1DF2B67Q48154391-8465FB1D-EBFD-4BA8-AF4C-6329B33C291EQ48571175-988CB1B3-C58D-4806-B022-2196D412CCE2Q53117801-E65383E7-9935-4A53-8CB7-E047ACE39EACQ53739408-2337E141-A7E4-45F4-B22F-D72223A7A778Q57348013-8AB363DA-3510-420A-91CB-E4B2A0444769Q58599760-A723B83F-4DBA-4EB7-AD76-5472CB04CE90
P2860
Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@ast
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@en
type
label
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@ast
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@en
prefLabel
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@ast
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@en
P2093
P356
P1433
P1476
Tumor accumulation of NIR fluo ...... d human xenograft tumor model.
@en
P2093
Achim Göpferich
Andreas Schädlich
Cornelia Rose
Frederike Tenambergen
Henrike Caysa
Judith Kuntsche
Thomas Mueller
P304
P356
10.1021/NN2026353
P407
P577
2011-10-10T00:00:00Z